Matthew Blahna

Matthew Blahna is currently the Breast Cancer Global Medical Strategy Lead in Medical Affairs at Pfizer. Previously, they held various roles at Seagen, including Medical Director and Associate Medical Director. Matthew's experience includes positions at Eli Lilly and Company as an Associate Consultant, and at the University of Michigan School of Public Health as a Graduate Student Instructor. They earned a BS in Biology from the University of Utah, an MPH in Molecular and Hospital Epidemiology from the University of Michigan, and a Ph.D. in Biology from Harvard University.